| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1517/14740338.4.1.91 |
| P698 | PubMed publication ID | 15709901 |
| P2093 | author name string | Robert L Rodnitzky | |
| P2860 | cites work | Neuroleptic Malignant Syndrome and Atypical Antipsychotic Drugs | Q22241106 |
| The serotonin syndrome and its treatment | Q28142633 | ||
| Worsening of motor features of parkinsonism with olanzapine | Q28377314 | ||
| Cocaine-associated dystonic reaction | Q30470903 | ||
| MDMA (ecstasy) and the rave: a review | Q30471049 | ||
| Psychoactive medication prescribing practices for U.S. children: gaps between research and clinical practice | Q33609015 | ||
| Clinical features and long-term treatment with pimozide in 65 patients with Gilles de la Tourette's syndrome | Q33622433 | ||
| Neuroleptic-induced Parkinson's syndrome: clinical features and results of treatment with levodopa | Q33631368 | ||
| Clozapine-associated neuroleptic malignant syndrome: two new cases and a review of the literature | Q33659395 | ||
| Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases. | Q33764246 | ||
| Managing antipsychotic-induced acute and chronic akathisia | Q33824853 | ||
| Trends in the prescribing of psychotropic medications to preschoolers | Q33891787 | ||
| Risperidone in children with autism and serious behavioral problems | Q33960551 | ||
| The Hunter Serotonin Toxicity Criteria: simple and accurate diagnostic decision rules for serotonin toxicity | Q33967821 | ||
| The serotonin syndrome | Q34021904 | ||
| Akathisia: a review and case report following paroxetine treatment | Q34062710 | ||
| Treatment of tardive dyskinesia | Q34065480 | ||
| Tetrabenazine therapy of dystonia, chorea, tics, and other dyskinesias | Q34172000 | ||
| Death following ingestion of MDMA (ecstasy) and moclobemide | Q34179506 | ||
| Efficacy of the branched-chain amino acids in the treatment of tardive dyskinesia in men. | Q34201539 | ||
| Akathisia: a comprehensive review and treatment summary | Q34326522 | ||
| Long-term effects of tetrabenazine in hyperkinetic movement disorders | Q34417087 | ||
| High serum creatinine kinase level: possible risk factor for neuroleptic malignant syndrome | Q34523098 | ||
| Neuroleptic malignant syndrome: a unique association with a tricyclic antidepressant | Q34635940 | ||
| Movement disorders in children and adolescents | Q35077736 | ||
| Pallidal and thalamic neurostimulation in severe tardive dystonia | Q35461412 | ||
| RETRACTED: Efficacy of methylprednisolone pulse therapy on neuroleptic malignant syndrome in Parkinson's disease | Q35473448 | ||
| Recognition and differential diagnosis of tardive dyskinesia | Q38366117 | ||
| In Search of Treatment for Tardive Dyskinesia: Review of the Literature* | Q39259811 | ||
| Acute dystonia induced by neuroleptic drugs | Q39439115 | ||
| Carbamazepine in the treatment of neuroleptic malignant syndrome. | Q39449943 | ||
| Prescribing of psychotropic drugs to children and adolescents | Q40080901 | ||
| The epidemiology of drug-induced akathisia: Part I. Acute akathisia. | Q40371439 | ||
| Incidence and risk factors in neuroleptic malignant syndrome | Q40613682 | ||
| Risperidone-induced neuroleptic malignant syndrome | Q40645066 | ||
| Drug-induced hyperthermia | Q40645990 | ||
| Selective serotonin reuptake inhibitor-induced serotonin syndrome: review | Q40650469 | ||
| Serotonin syndrome complicating migraine pharmacotherapy | Q40665493 | ||
| Neuroleptic malignant syndrome: two cases without muscle rigidity | Q40667422 | ||
| Sertraline intoxication in a child | Q40699964 | ||
| Sumatriptan contraindications and the serotonin syndrome. | Q41707189 | ||
| Predictors of acute dystonia in first-episode psychotic patients. | Q42282739 | ||
| Neuroleptic malignant syndrome and methylphenidate | Q42538017 | ||
| A case of serotonin syndrome caused by venlafaxine and lithium | Q42545440 | ||
| Neuroleptic malignant syndrome without fever: a report of three cases | Q43071575 | ||
| The neuroleptic malignant syndrome: a logical approach to the patient with temperature and rigidity | Q43199767 | ||
| Pediatric stimulant and selective serotonin reuptake inhibitor prescription trends: 1992 to 1998. | Q43601365 | ||
| Association of the TaqI A polymorphism of the dopamine D(2) receptor gene with predisposition to neuroleptic malignant syndrome | Q43752220 | ||
| Phenytoin-induced choreoathetosis in patients with severe myoclonic epilepsy in infancy | Q43826996 | ||
| Cyproheptadine versus propranolol for the treatment of acute neuroleptic-induced akathisia: a comparative double-blind study | Q43837437 | ||
| Anticonvulsants-induced chorea: a role for pharmacodynamic drug interaction? | Q43855188 | ||
| Acute dystonic reactions to "street Xanax". | Q44010607 | ||
| Lack of association in Japanese patients between neuroleptic malignant syndrome and the TaqI A polymorphism of the dopamine D2 receptor gene | Q44327745 | ||
| Clozapine-induced akathisia in children with schizophrenia | Q44355034 | ||
| Long‐term outcome of quetiapine use for psychosis among parkinsonian patients | Q44423672 | ||
| Akathisia as a side effect of antipsychotic treatment with quetiapine in a patient with Parkinson's disease | Q44464254 | ||
| Ziprasidone-induced oculogyric crisis | Q44578692 | ||
| Quetiapine, clozapine, and olanzapine in the treatment of tardive dyskinesia induced by first-generation antipsychotics: a 124-week case report | Q44626929 | ||
| Case-control study of neuroleptic malignant syndrome. | Q44635424 | ||
| A Pilot Study of Risperidone, Olanzapine, and Haloperidol in Psychotic Youth: A Double-Blind, Randomized, 8-Week Trial | Q44635621 | ||
| Citalopram and dystonia | Q44703404 | ||
| Ziprasidone in Parkinson's disease psychosis | Q44756176 | ||
| Ziprasidone-related neuroleptic malignant syndrome in a patient with Parkinson's disease: a diagnostic challenge | Q44840481 | ||
| Aripiprazole for drug-induced psychosis in Parkinson disease: preliminary experience | Q44848477 | ||
| Serotonin syndrome and linezolid | Q44949257 | ||
| Naltrexone treatment of tardive dyskinesia in patients with schizophrenia | Q44962409 | ||
| Neuroleptic-related dyskinesias in autistic children: a prospective, longitudinal study | Q50302476 | ||
| Haloperidol in the treatment of infantile autism: effects on learning and behavioral symptoms | Q50344620 | ||
| A treatment for tardive dyskinesia and some other extrapyramidal symptoms. | Q50953514 | ||
| Intravenous benztropine and propranolol challenges in tardive akathisia. | Q51146725 | ||
| Plasmapheresis in neuroleptic malignant syndrome. | Q51549053 | ||
| The effect of vitamin E treatment on tardive dyskinesia and blood superoxide dismutase: a double-blind placebo-controlled trial. | Q51944305 | ||
| A survey of herbal use in children with attention-deficit-hyperactivity disorder or depression. | Q51950526 | ||
| Use of psychotropic agents in preschool children: associated symptoms, diagnoses, and health care services in a health maintenance organization. | Q51950628 | ||
| Risperidone-induced tardive dyskinesia and parkinsonism | Q57982354 | ||
| Vitamin E (α-Tocopherol) in the Treatment of Tardive Dyskinesia: A Statistical Meta-Analysis | Q58255890 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | movement disorders | Q2608695 |
| P304 | page(s) | 91-102 | |
| P577 | publication date | 2005-01-01 | |
| P1433 | published in | Expert Opinion on Drug Safety | Q5421206 |
| P1476 | title | Drug-induced movement disorders in children and adolescents | |
| P478 | volume | 4 |
| Q36852604 | Behavioral effects and pharmacokinetics of (±)-3,4-methylenedioxymethamphetamine (MDMA, Ecstasy) after intragastric administration to baboons |
| Q83642533 | Drug-induced parkinsonism |
| Q37590848 | Epidemiology and management of essential tremor in children |
| Q48343539 | Epilepsy, parkinsonism, and neuroleptic malignant syndrome in a child. |
| Q46789002 | Metoclopramide, an increasingly recognized cause of tardive dyskinesia |
| Q36024152 | Rash in psychiatric and nonpsychiatric adolescent patients receiving lamotrigine in Korea: a retrospective cohort study |
| Q37762257 | Tardive dyskinesia and withdrawal emergent syndrome in children |
Search more.